Literature DB >> 23320432

Isolated unilateral tongue oedema: the adverse effect of Angiotensin converting enzyme inhibitors.

Edmund Leung1, Marcelino Yazbek Hanna, Nadeem Tehami, James Francombe.   

Abstract

Angiotensin converting enzyme inhibitors (ACEI) are widely used to treat benign hypertension. These drugs are generally well tolerated. Serious side effects such as angio-oedema are very rare. The authors report a 64-year-old Caucasian woman with a history of liver transplant on Mammalian Target Of Rapamycin (mTOR) inhibitor, who attended Emergency department with angio-oedema only on the left side of her tongue. Her airway was patent and she was haemodynamically stable. Trauma was denied. Her physician had 2 days earlier commenced her on Lisinopril for newly diagnosed benign hypertension. Intravenous steroids and anti-histamine were immediately administered. A good response of oedema subsidence was noted. In general, angio-oedema can present in a spectrum of severity. Precipitating factors are often difficult to pre-determine and avoid. Early recognition of risk factors for and diagnosis of angio-oedema can often be life-saving.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23320432     DOI: 10.2174/157488612805076561

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  3 in total

Review 1.  Curious Cases of the Enzymes.

Authors:  Nuriye Nuray Ulusu
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

Review 2.  Oral adverse effects: drug-induced tongue disorders.

Authors:  Yalda Aziz; Willem Maria Hubertus Rademacher; Atty Hielema; Scott Bradley Patton Wishaw; Denise Edwina van Diermen; Jan de Lange; Arjan Vissink; Frederik Reinder Rozema
Journal:  Oral Dis       Date:  2020-11-03       Impact factor: 3.511

3.  Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report.

Authors:  Zamzam Khalaf Al-Hoqani; Maisa Hamed Al-Kiyumi; Salem Hamdan Al-Tamemi; Abdulaziz Mahmood Al-Mahrezi
Journal:  Oman Med J       Date:  2020-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.